Alternatives to JCR Pharmaceuticals

A biopharmaceutical company focused on developing and commercializing therapies for rare diseases.

A global oncology company developing and commercializing innovative cancer treatments.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Biotech company developing next-generation gene writing tools for advanced therapies.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Gene therapy company developing treatments for rare inherited diseases.

Gene therapy company developing transformative treatments for severe genetic diseases.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

Diversified biopharmaceutical company focused on rare diseases, generics, and established brands.

Developing advanced cell culture media and bioprocessing solutions for cell and gene therapy.

Develops long-acting implantable and injectable therapies for opioid addiction and chronic pain.

A biotechnology company developing small molecule drugs to treat neurodegenerative diseases by targeting mitochondrial dysfunction.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

A biotechnology company developing genetic therapies for rare disorders.

AI-powered platform accelerating biological research and drug discovery.

Develops advanced gene editing and cell therapy solutions for rare genetic diseases.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.